Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Alert: Update in Lawsuit

A lawsuit is pending on behalf of certain investors in Clover Health Investments, Corp. (NASDAQ:CLOV) shares over alleged securities laws violations.

San Diego, CA — (SBWIRE) — 04/22/2022 — The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Clover Health Investments, Corp. (NASDAQ: CLOV), over alleged violations of Federal Securities Laws by Clover Health Investments, Corp. (formerly Social Capital Hedosophia Holdings Corp. III).

Investors who purchased shares of Clover Health Investments, Corp. (formerly Social Capital Hedosophia Holdings Corp., NASDAQ: CLOV, CLOVW, NYSE: IPOC) prior to October 2020, and continue to hold any of your Clover Health Investments, Corp shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On February 5, 2021, a lawsuit was filed against Clover Health Investments, Corp over alleged Securities Laws Violations. The plaintiff alleged that the defendants between October 6, 2020 and February 4, 2021 and in the registration statement issued in connection with the December 2020 Merger of Clover and Social Capital III made false and/or misleading statements and/or failed to disclose that Clover’s Clover Assistant platform was under active investigation by the Department of Justice (“DOJ”) for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals, that the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare, that Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology, that a significant portion of Clover’s sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales, and that as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On June 28, 2021, an amended Complaint was filed and on August 27, 2021, the Defendants filed a Motion to Dismiss the amended Complaint.

Then, on February 28, 2022, the Court issued an Order denying Defendants’ Motion to Dismiss.

Those who purchased shares of Clover Health Investments, Corp. (NASDAQ: CLOV) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/clover-health-investments-corp-nasdaqclov-investor-alert-update-1356533.htm

Media Relations Contact

Michael Daniels
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Michael Daniels
Web: https://www.shareholdersfoundation.com/